ArticleJournal of immigrant and minority health2026
Clinical Characteristics of Metabolic Dysfunction Steatotic Liver Disease in Asian-American Patients with Chronic Hepatitis B.
Article in Journal of immigrant and minority health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this project was to determine the prevalence of fatty liver among Asian-American patients with chronic hepatitis B in a real-world setting, and to characterize the demographic, body composition and clinical features of these patients. This was a retrospective cross-sectional study of 115 Asian-American CHB patients followed at two clinical liver disease community programs in Southern California. Patients underwent standardized interviews, physical exams, body composition analysis (InBody® scan), laboratory studies, and assessment of liver stiffness and fat by FibroScan®. The median BMI of the cohort was 24.4 kg/m2, CAP was 250 dB/m, and liver stiffness was 5.0 kPa. Patients whose BMI were > 23 kg/m2 showed a significant increase in hepatic steatosis, percent body fat, years lived in the US, prevalence and number of metabolic syndrome components (obesity, hypertension, type 2 diabetes mellitus). Asians who immigrate to the US at a younger age have an increased risk of elevated BMI and consequent risk of MASLD. Body composition and liver disease progression differences across BMI in our cohort support the need for population-specific anthropometric parameters and underscores a BMI of 23 kg/m2 as an important cutoff point in characterizing progressive liver disease in Asian-Americans with CHB. The increased risk of MASLD seen in our cohort may be due to the impact of acculturation.
Indexed as
Identifiers
41838324What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.